Concord Biotech Files Annual Report for FY 2025-26

Concord Biotech Limited has submitted its Annual Report for the financial year 2025-26, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report details the company's performance, corporate overview, financial statements, and management reports. It emphasizes the company's commitment to creating enduring value through innovation, operational excellence, and sustainable practices. The report covers various aspects of the company's operations, including its strategic blueprint, risk management, and value creation model across intellectual, manufactured, financial, human, natural, and social capital. It also includes the Director's Report, Corporate Governance Report, Business Responsibility & Sustainability Report, and Management Discussion & Analysis.